Workers Compensation
The earlier a high-risk profile is spotted, the better the outcome. Medication education for case managers gives teams the knowledge to recognise high-risk medications and know when a pharmacy review is warranted.
What does medication education for case managers cover?
Medication education for case managers is practical, claim-based training that turns a claims team into an early warning system. Rather than abstract pharmacology, the session focuses on what a case manager can see on a file and what to do about it.
- How to identify high-risk medications and concerning combinations on a claim.
- The warning signs of polypharmacy, escalation and dependence.
- Clear referral triggers, so reviews happen at the right moment rather than too late.
- How medication issues connect to claim duration and return-to-work outcomes.
- Where IMM's review, monitoring and counselling services fit the claim lifecycle.
Why train case managers to spot the right claims?
Training a case management team to spot the right claims is one of the highest-leverage things an insurer can do. High-risk medication training for an insurer reduces the time a dangerous profile goes unaddressed and lifts the quality of every referral that follows, which means fewer late interventions and better claim outcomes.
What are the referral triggers?
Sessions give case managers concrete referral triggers for injury claims: opioids or benzodiazepines continuing beyond the expected window, three or more centrally acting medications, escalating doses, or polypharmacy warning signs across multiple prescribers. Knowing when to refer for a pharmacy review is the difference between early action and cleanup.
Who delivers the sessions?
Sessions are delivered by the same clinical pharmacists who conduct IMM's reviews, so the content is grounded in real claims rather than theory.
How are sessions tailored to your scheme?
Sessions are scoped to your scheme, whether workers compensation or CTP, and to the medication profiles your portfolio actually sees. They can run as one-off briefings or as an ongoing capability programme, including a regular check-in cadence for high-volume teams.
Key Takeaways
- Early identification of high-risk medication improves both the claim and the person.
- Education is claim-based and practical, not abstract pharmacology.
- Clear referral triggers mean reviews happen at the right moment, not too late.
- Sessions are delivered by the pharmacists who conduct the reviews.
- Content is scoped to your scheme and the profiles your portfolio sees.
Frequently Asked Questions
What will a case management team take away from a session?
Teams learn how to identify high-risk medications and concerning combinations, the warning signs of polypharmacy and dependence, clear referral triggers, and how medication issues connect to claim duration and return-to-work outcomes.
When should a case manager refer for a pharmacy review?
Sessions set out clear referral triggers so reviews happen at the right moment rather than too late, typically when high-risk medications, escalation or polypharmacy appear on a claim.
Who delivers the education?
Sessions are delivered by the same clinical pharmacists who conduct IMM's reviews, so the content is grounded in real claims rather than theory, backed by a proprietary 480-hour training programme.
Can sessions be tailored to our scheme?
Yes. Sessions are scoped to your scheme, whether workers compensation or CTP, and to the medication profiles your portfolio actually sees, as a one-off briefing or an ongoing capability programme.
Primary source: Pharmaceutical Society of Australia (PSA), Medicine Safety: Take Care report, 2019.
